Source: centralcharts

Press Release: Entasis Therapeutics : Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update

WALTHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Manos Perros's photo - President & CEO of Entasis Therapeutics Holdings, Inc.

President & CEO

Manos Perros

CEO Approval Rating

89/100

Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more